Business Description
![Immunogen Inc Immunogen Inc logo](https://static.gurufocus.com/logos/0C00000BFC.png?14)
Immunogen Inc
NAICS : 325412
SIC : 2834
ISIN : US45253H1014
Share Class Description:
IMGN: Ordinary SharesDescription
Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.18 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -1.38 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 18.2 | |||||
Beneish M-Score | 9.36 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.2 | |||||
3-Year EBITDA Growth Rate | -14.9 | |||||
3-Year EPS without NRI Growth Rate | -15.2 | |||||
3-Year FCF Growth Rate | -14 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 94.62 | |||||
9-Day RSI | 88.02 | |||||
14-Day RSI | 82.52 | |||||
6-1 Month Momentum % | 107.1 | |||||
12-1 Month Momentum % | 584.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.7 | |||||
Quick Ratio | 5.65 | |||||
Cash Ratio | 4.5 | |||||
Days Inventory | 294 | |||||
Days Sales Outstanding | 62.45 | |||||
Days Payable | 2664.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.6 | |||||
Shareholder Yield % | -0.37 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 98.66 | |||||
Operating Margin % | -27.88 | |||||
Net Margin % | -25.56 | |||||
FCF Margin % | -69.46 | |||||
ROE % | -24.37 | |||||
ROA % | -14.52 | |||||
ROIC % | -86.86 | |||||
ROC (Joel Greenblatt) % | -323.14 | |||||
ROCE % | -15.88 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 156.25 | |||||
PS Ratio | 29.32 | |||||
PB Ratio | 14.78 | |||||
Price-to-Tangible-Book | 14.8 | |||||
EV-to-EBIT | -130.67 | |||||
EV-to-EBITDA | -134.36 | |||||
EV-to-Forward-EBITDA | -17.19 | |||||
EV-to-Revenue | 28.52 | |||||
EV-to-Forward-Revenue | 16.25 | |||||
EV-to-FCF | -41.06 | |||||
Price-to-Median-PS-Value | 2.95 | |||||
Price-to-Net-Current-Asset-Value | 16.44 | |||||
Price-to-Net-Cash | 24.02 | |||||
Earnings Yield (Greenblatt) % | -0.77 | |||||
FCF Yield % | -2.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immunogen Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 287.614 | ||
EPS (TTM) ($) | -0.31 | ||
Beta | 0 | ||
Volatility % | 179.35 | ||
14-Day RSI | 82.52 | ||
14-Day ATR ($) | 0.298673 | ||
20-Day SMA ($) | 29.811 | ||
12-1 Month Momentum % | 584.14 | ||
52-Week Range ($) | 3.605 - 31.25 | ||
Shares Outstanding (Mil) | 279.35 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Immunogen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Immunogen Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Immunogen Inc Frequently Asked Questions
What is Immunogen Inc(IMGN)'s stock price today?
The current price of IMGN is $31.23. The 52 week high of IMGN is $31.25 and 52 week low is $3.61.
When is next earnings date of Immunogen Inc(IMGN)?
The next earnings date of Immunogen Inc(IMGN) is 2024-07-31 Est..
Does Immunogen Inc(IMGN) pay dividends? If so, how much?
Immunogen Inc(IMGN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |